Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study

DOI:10.1016/j.annonc.2024.12.002
作者：L. Zhou ,?K.W. Yang ,?S. Zhang ,?X.Q. Yan ,?S.M. Li ,?H.Y. Xu ,?J. Li ,?Y.Q. Liu ,?B.X. Tang ,?Z.H. Chi ,?L. Si ,?C.L. Cui ,?H.Q. Guo ,?Z.S. He ,?J. Guo ,?X. Sheng
文献类型：期刊论文
补充材料：只需要正文